---
document_datetime: 2023-09-21 19:46:44
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/gardasil-9-epar-all-authorised-presentations_en.pdf
document_name: gardasil-9-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.3206886
conversion_datetime: 2025-12-23 23:43:44.963037
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form      | Route of administration   | Immediate Packaging        | Content (concentration)   | Pack size                |
|------------------|-------------------|------------|--------------------------|---------------------------|----------------------------|---------------------------|--------------------------|
| EU/1/15/1007/001 | Gardasil 9        | --1        | Suspension for injection | Intramuscular use         | vial (glass)               | 0.5 ml                    | 1 vial                   |
| EU/1/15/1007/002 | Gardasil 9        | --1        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 syringe + 2 needles    |
| EU/1/15/1007/003 | Gardasil 9        | --1        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 syringes + 20 needles |
| EU/1/15/1007/004 | Gardasil 9        | --1        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 syringes              |

- --1 1 dose (0.5 ml) contains approximately:

| Human   | Papillomavirus1 Type 6 L1 protein 2,3 30 micrograms   |
|---------|-------------------------------------------------------|
| Human   | Papillomavirus1 Type 11 L1 protein 2,3 40 micrograms  |
| Human   | Papillomavirus1 Type 16 L1 protein 2,3 60 micrograms  |
| Human   | Papillomavirus1 Type 18 L1 protein 2,3 40 micrograms  |
| Human   | Papillomavirus1 Type 31 L1 protein 2,3 20 micrograms  |
| Human   | Papillomavirus1 Type 33 L1 protein 2,3 20 micrograms  |
| Human   | Papillomavirus1 Type 45 L1 protein 2,3 20 micrograms  |
| Human   | Papillomavirus1 Type 52 L1 protein 2,3 20 micrograms  |
| Human   | Papillomavirus1 Type 58 L1 protein 2,3 20 micrograms  |

¹ Human Papillomavirus = HPV

² L1 protein in the form of virus-like particles produced in yeast cells ( Saccharomyces cerevisiae CANADE 3C-5 (Strain 1895)) by recombinant DNA technology

³ adsorbed on amorphous aluminium hydroxyphosphate sulphate adjuvant (0.5 milligrams Al)